Jay T. Rubinstein, MD, PhD, highlighted promising CHORD trial data showing that DB-OTO gene therapy has led to hearing improvements in treated participants.
Jay Rubinstein, MD, PhD
Advertisement
Articles by Jay Rubinstein, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Full case: A 19-year-old boy with Down syndrome and progressive loss of communication?
2
FDA news in pediatrics: July 2026
3
Jamie Fleming, MD, discusses the underrecognition of pediatric chronic pain, urges earlier referral
4
Hot dogs, grapes, and holiday plates: Helping kids eat safely this summer
5